expected in Q4 2024 On track for topline progression-free survival data from the phase 2b randomized controlled clinical trial of CAN-2409 in the active surveillance population with localized ...

In the active surveillance era, overtreatment of men with limited life expectancy (LE) decreased for those with low-risk ...

OVERTREATMENT of prostate cancer persists among men with limited life expectancy within the Veterans Affairs (VA) health system. Despite the adoption of active surveillance, particularly for low-risk ...

Overtreatment of prostate cancer is increasing in the United States among men with limited life expectancy, a new study ...

Investigators conducted a trial of MRI as a screening tool to reduce overdetection of insignificant prostate cancer.

Prostate cancer treatment guidelines recommend against aggressive therapy for those with a life expectancy of less than 10 years.

A recent study led by Cedars-Sinai researchers reveals that a growing number of older men in the U.S. with intermediate or ...

Among patients with average life expectancies of less than 10 years, the proportion who underwent treatments such as surgery ...

Increasing percentages of some older U.S. men with intermediate-risk and high-risk prostate cancers are undergoing treatments that carry risks of side effects that can significantly reduce the quality ...

The men were under active surveillance as they took white button mushroom supplements ... in MDSCs is associated with ...

At the same time, aggressive treatment declined in men with low-risk prostate cancer as might have been expected in an era ...

Increasing numbers of older U.S. men with prostate cancer are undergoing treatments that carry risks of side effects that can ...